Biotechnology company devoted to research of restoring human health
UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.
Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial focus is on delivering localized therapy in ophthalmologic diseases, including diabetic macular edema and age-related macular degeneration, and age-related neurologic conditions.
Visit website: https://unitybiotechnology.com/
People at UNITY Biotechnology
Chief Executive Officer at UNITY Biotechnology.
Co-Founder and President at Unity Biotechnology.
Co-Founder and President, Unity Biotechnology
Chairman and CEO of UNITY Biotechnology.
Chief Medical Officer at Unity Biotechnology.
UNITY Biotechnology News
Longevity Technology interviews Aubrey de Grey about senolytics and other senotherapeutics
Longevity Technology - 05-Aug-2021
Most approaches have their limitations but good progress is being made on several frontsRead more...
Unity's senolytic drug reports positive phase 1 data in eye disease patients
FierceBiotech - 06-Jul-2021
Begun phase 2 trial including patients with early stage of disease to test its safety and effectivenessRead more...
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...
LMC provides background and success outlook on 14 leading senolytic companies
Longevity Marketcap - 15-Dec-2020
Comprehensive review of companies' clinical and financial state of playRead more...
Unity Biotechnology launches clinical trial of a new senolytic
Lifespan.io (LEAF) - 13-Oct-2020
A new approach to treat diabetic macular oedemaRead more...
Labiotech gathers feedback from European biotechs on Unity failure
Labiotech - 28-Aug-2020
General feeling that failures are bound to happen - but that their approaches can succeedRead more...
Reason examines the failure of Unity Biotechnology's phase 2 senolytics trial
Fight Aging! - 18-Aug-2020
Disappointing first result - but lessons learnt and plenty of other strategies availableRead more...
Research into klotho is at a very interesting point
Fight Aging! - 03-Jun-2019
Research community is littered with interesting, promising foundations for therapies to treat agingRead more...
UNITY Biotechnology expands trial of osteoarthritis senolytic
UNITY Biotechnology - 22-Jan-2019
Initial results must be promising to enrol more patients at highest dosageRead more...
UNITY Biotechnologies Selects a New Senolytic Candidate
Lifespan.io (LEAF) - 14-Jan-2019
Very early days but good to have more senolytics in the pipelineRead more...
The path to an extended health span and a healthier death
MIT Technology Review - 23-Oct-2018
Still a long way to go before expanding life spanRead more...
Cleara Biotech Joins the Race to Develop Senolytic Therapies
Lifespan.io (LEAF) - 09-Jul-2018
This therapy uses a modified FOXO4 to promote apoptosis in senescent cellsRead more...
Silicon Valley and rich people invest to slow down ageing and live longer
This Is Money - 17-Mar-2018
All the money in the world to fight ageing and deathRead more...
SRF has made progress in the fight against ageing
Lifespan.io (LEAF) - 05-Dec-2017
R&D phase in SENS repair approach has shown promising resultsRead more...
Here are the ways Silicon Valley plans to conquer death
National Post - 03-Nov-2017
Billionaires are now pouring millions into longevity research. Upgrading the human immune system...Read more...
To stay young, kill zombie cells
Nature - 24-Oct-2017
Proof-of-concept trials starting that pit senolytic drugs against a range of age-related ailments...Read more...
Treating Osteoarthritis by Removing Senescent Cells
Lifespan.io (LEAF) - 03-May-2017
Researchers used local clearance of senescent cells (in mice) to reduce the development of post-t...Read more...
Hallmark of Aging Reversed by Senescent Cell Removal
Lifespan.io (LEAF) - 25-Mar-2017
Study directly targets one of the mechanisms that senescent cells use to avoid apoptosis, Focuse...Read more...
Exciting Therapy To Treat Age Related Blindness Moving To The Clinic
Lifespan.io (LEAF) - 15-Feb-2017
Ichor Therapeutics is a biotechnology company focused on developing drugs for age-related disease...Read more...
Fight Aging predicts the sequence of arrival for meaningful antiaging therapies
Next Big Future - 01-Dec-2016
Each treatment will target a different type of molecular damage in cells and tissues. 1) Clearan...Read more...
Display all news